Pharmaceutical Technology
JPM26: AbbVie highlights growth drivers as it moves away from Humira dependency
📈
AI Sentiment
Highly Positive
9/10
Teva Pharmaceutical Industries Limited News
Latest updates and market news for TEVA
16 news
Jan 11 - Jan 17, 2026
Page 1
MT Newswires
Neurocrine Biosciences Says Ingrezza Shows Greater Potency Than Austedo
âž–
AI Sentiment
Neutral
5/10
Zacks
Teva Pharmaceutical Industries Ltd. (TEVA) is a Top-Ranked Momentum Stock: Should You Buy?
âž–
AI Sentiment
Neutral
5/10
MT Newswires
Teva Pharmaceutical's Ajovy Reduces Migraine Days in Children
âž–
AI Sentiment
Neutral
5/10
Simply Wall St.
Is It Too Late To Reassess Teva (TEVA) After A 55% One Year Rally?
📊
AI Sentiment
Positive
6/10
Barrons.com
Teva Stock Is Jumping. Why Investors Are So Optimistic on the Drugmaker.
📊
AI Sentiment
Positive
7/10
Zacks
TEVA Signs Deal With RPRX to Accelerate Development of Vitiligo Drug
📈
AI Sentiment
Highly Positive
9/10
Zacks
Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Top Value Stock for the Long-Term
âž–
AI Sentiment
Neutral
5/10
MT Newswires
Teva Pharmaceutical Industries Reiterates 2025 Earnings, Revenue Guidance
âž–
AI Sentiment
Neutral
5/10
MT Newswires
Teva's US Affiliate, Royalty Pharma Sign $500 Million Financing Deal for Potential Vitiligo Treatment
âž–
AI Sentiment
Neutral
5/10
GlobeNewswire
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation
📈
AI Sentiment
Highly Positive
8/10
Share this news page